STOCK TITAN

Marsh & Mclennan SEC Filings

MMC NYSE

Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Marsh & McLennan Companies, Inc., doing business as Marsh McLennan, files reports with the US Securities and Exchange Commission as a public company with common stock listed on the New York Stock Exchange. This SEC filings page for MMC provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other filings that document material events, governance changes and financial reporting updates.

Recent Form 8-K filings illustrate the types of information Marsh McLennan reports. One filing describes amendments and restatements of the company’s bylaws, noting updates to align with changes in the Delaware General Corporation Law, revisions to advance notice provisions for director nominations and stockholder proposals, clarification of voting standards for matters submitted to stockholders, and clarification of the authority of the chair of stockholder meetings. Other 8-K filings disclose quarterly financial results, conference calls to discuss those results, and board-level changes such as the appointment of an independent director to the Board and Audit Committee.

Filings also show details about Marsh McLennan’s capital structure and listing status, including the registration of its common stock, par value $1.00 per share, and the trading symbols under which it is listed on the New York Stock Exchange. Investors can review these filings to understand how Marsh McLennan communicates material events, corporate governance changes and financial information.

On Stock Titan, Marsh McLennan’s SEC filings are paired with AI-powered tools that can help explain the contents of lengthy documents, highlight key sections, and surface items such as current reports, annual and quarterly reports, and disclosures about governance or board changes. This makes it easier to navigate Marsh McLennan’s regulatory history, track updates over time, and connect specific filings to news and other public communications about the company.

Rhea-AI Summary

Marsh & McLennan Companies director Deborah C. Hopkins reported receipt of restricted stock units under the company's Directors Stock Compensation Plan that convert 1-for-1 into common stock. The transaction dated 08/15/2025 shows 85.08 underlying shares (acquired with dividend equivalents) and reports 19,752.73 shares beneficially owned following the transaction on a direct basis. The filing was executed by an attorney-in-fact on 08/18/2025. No exercise price or derivative expiration applies because these are restricted stock units that convert to common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marsh & McLennan Companies director Lloyd M. Yates received restricted stock units under the company's Directors Stock Compensation Plan that convert 1-for-1 into common stock. The Form 4 reports two grant entries tied to director fees and dividend equivalents, showing 174.23 and 43.37 restricted stock units credited, with a reported per-share reference price of $208.055. The report shows the reporting person's beneficial ownership in common stock at 10,243.63 shares following the reported transactions. The filing documents routine, compensation-related equity awards to a director and does not disclose sales, purchases for cash, or other non-compensation transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Report of director equity awards and dividend-equivalent credit. Jane H. Lute, a director of Marsh & McLennan Companies, Inc. (MMC), received restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan with transaction dates of 08/15/2025. One grant shows 130.67 restricted stock units acquired in connection with director fees, and a second entry shows 29.48 restricted stock units acquired from dividend equivalents. The security converts 1-for-1 into MMC common stock. Following these transactions, the reporting person beneficially owned 6,974.89 shares (the filing shows 6,945.41 following the first entry and 6,974.89 after the second). The form was signed by an attorney-in-fact on 08/18/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marsh & McLennan Companies (MMC) director Steven A. Mills reported an acquisition of company common stock as director compensation. On 08/15/2025 he acquired 204 shares at an average price of $208.055 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After the transaction, the filing shows Mr. Mills beneficially owns 3,669.75 shares directly and 47,553 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on 08/18/2025 and discloses the acquisition was compensation-related.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marsh & McLennan Companies director Tamara Ingram reported acquisition of 32.8 restricted stock units under the company's Directors Stock Compensation Plan, treated as converting 1-for-1 into common stock. The units were acquired via dividend equivalents and are recorded with a per-share reference price of $208.055. After this grant the reporting person’s beneficial ownership is shown as 7,616.23 shares (direct).

The Form 4 discloses a routine compensation-related grant to a director rather than an open-market trade, indicating equity received as part of director pay rather than a purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Siegmund Jan, a director of Marsh & McLennan Companies, Inc. (MMC), reported a non-derivative acquisition on 08/15/2025. The filing shows the reporting person received Restricted Stock Units under the Marsh & McLennan Companies Directors Stock Compensation Plan that convert 1-for-1 into common stock. The transaction was recorded as resulting in 933.67 shares beneficially owned following the award and was acquired with dividend equivalents credited to the reporting person’s account. The Form 4 was signed by an attorney-in-fact on 08/18/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Form 4 shows that Morton O. Schapiro, a director of Marsh & McLennan Companies, Inc. (MMC), received restricted stock units under the companys Directors Stock Compensation Plan on 08/15/2025. Two entries are reported: 198.26 restricted stock units acquired in connection with director fees and 373.86 restricted stock units credited as dividend equivalents. The security converts 1-for-1 into MMC common stock. Following these transactions the filing reports beneficial ownership figures of 86,624.11 and 86,997.97 shares on the respective lines. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
current report

FAQ

How many Marsh & Mclennan (MMC) SEC filings are available on StockTitan?

StockTitan tracks 90 SEC filings for Marsh & Mclennan (MMC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Marsh & Mclennan (MMC)?

The most recent SEC filing for Marsh & Mclennan (MMC) was filed on August 18, 2025.